Said, That is an extremely exciting new development.S. In the years to come. The move is part of Alpha Imaging's technique to deliver new clinical and complex services to their customers. .. Alpha Imaging announces acquisition of Chesapeake Applications Alpha Imaging LLC, a leading distributor of advanced medical imaging gear located in Cleveland, Ohio, today announced they have acquired Chesapeake Applications Inc., a Pennsylvania-based firm, to enhance their clinical applications teaching portfolio. The acquisition of Chesapeake Applications enhances the delivery of clinical support to our growing Shimadzu, Canon and Konica installed base, said Michael Perrico, CEO of Alpha Imaging. Welcoming the acquisition, Lloyd Kremser, President of Chesapeake Applications, Inc.Pending successful outcome, this scholarly research may lead to evaluation of extra monoclonal antibodies, targeting different epitopes, manufactured to safeguard humans from illness. Related StoriesBasic study for developing toxoplasma vaccine underwayGHIT Fund invests $10.7 million to battle malaria, TB, leishmaniasis and dengueAnalyzing potential TB vaccine Through the use of CMC Biologics' 2.012 accelerated monoclonal antibody development solution, we can help MVI achieve its mission to accelerate the development of promising malaria vaccines, for much needed use in the developing globe, stated Gustavo Mahler, PhD, Global Chief Procedures Officer, CMC Biologics. We chose CMC Biologics as our CMO partner for his or her sophisticated technical capabilities, effective background in the industry, and speed of antibody creation and development, stated Ashley J.